QQ客服 官方微博 反馈留言

	A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia
	Xu, Shaoyong; Liu, Xiangyang; Ming, Jie; Chen, Shenren; Wang, Yangang; Liu, Xiumei; Liu, Hong; Peng, Yongde; Wang, Jianqin; Lin, Jinying
刊名	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
	2015
卷号	18期号:6
关键词	allopurinol febuxostat gout hyperuricemia
ISSN号	1756-1841
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3544158
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Xu, Shaoyong,Liu, Xiangyang,Ming, Jie,et al. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES,2015,18(6).
APA	Xu, Shaoyong.,Liu, Xiangyang.,Ming, Jie.,Chen, Shenren.,Wang, Yangang.,...&Ji, Qiuhe.(2015).A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES,18(6).
MLA	Xu, Shaoyong,et al."A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia".INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 18.6(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。